FOQUEST has now been included on the Ontario Drug Benefit (ODB) formulary as of April 28, 2023
Foquest has now been included on the Ontario Formulary, effective April 28, 2023. Foquest is covered as a General Benefit (with therapeutic notes) on the Ontario Drug Benefit (ODB) Formulary for the treatment of persons with Attention Deficit with/without Hyperactivity Disorder.
Learn more about the eligibility criteria for reimbursement of Foquest in Ontario.